- call +1-201-465-4211
- email sales@mrinsights.biz
An infectious disease caused by the bacterium Mycobacterium tuberculosis (MTB) is known as Tuberculosis (TB). Tuberculosis generally affects the lungs, but can also affect other parts of the body.
Scope of the Report:
The rising screening rate in the high burden regions, faster clinical decisions, and affordability of diagnostics, advanced methodologies, and reduction in mortality rate are the major areas of development.
The global Tuberculosis Diagnosis and Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Tuberculosis Diagnosis and Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Tuberculosis Diagnosis and Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Tuberculosis Diagnosis and Treatment market by product type and applications/end industries.
Market Segment by Companies, this report covers
Abbott Laboratories
Akonni Biosystems
Thermo Fisher Scientific
BD
Bio-Synth
bioMérieux
Cepheid
Eiken Chemical
Epistem
Roche
GSK
Hain Lifesciences
Hologic
Labatec
Lupin
Otsuka Novel Products
QIAGEN
Sandoz
Sanofi
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Laboratory testing
Nucleic acid tests
Mantoux test
Radiography
Drug susceptibility test
Market Segment by Applications, can be divided into
Hospitals
Government organizations
Individual
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Tuberculosis Diagnosis and Treatment Market Overview
1.1 Product Overview and Scope of Tuberculosis Diagnosis and Treatment
1.2 Classification of Tuberculosis Diagnosis and Treatment by Types
1.2.1 Global Tuberculosis Diagnosis and Treatment Revenue Comparison by Types (2017-2023)
1.2.2 Global Tuberculosis Diagnosis and Treatment Revenue Market Share by Types in 2017
1.2.3 Laboratory testing
1.2.4 Nucleic acid tests
1.2.5 Mantoux test
1.2.6 Radiography
1.2.7 Drug susceptibility test
1.3 Global Tuberculosis Diagnosis and Treatment Market by Application
1.3.1 Global Tuberculosis Diagnosis and Treatment Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Government organizations
1.3.4 Individual
1.4 Global Tuberculosis Diagnosis and Treatment Market by Regions
1.4.1 Global Tuberculosis Diagnosis and Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Tuberculosis Diagnosis and Treatment Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Tuberculosis Diagnosis and Treatment Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Tuberculosis Diagnosis and Treatment Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Tuberculosis Diagnosis and Treatment Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Tuberculosis Diagnosis and Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Tuberculosis Diagnosis and Treatment (2013-2023)
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Business Overview
2.1.2 Tuberculosis Diagnosis and Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Laboratories Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 Akonni Biosystems
2.2.1 Business Overview
2.2.2 Tuberculosis Diagnosis and Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Akonni Biosystems Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Thermo Fisher Scientific
2.3.1 Business Overview
2.3.2 Tuberculosis Diagnosis and Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Thermo Fisher Scientific Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 BD
2.4.1 Business Overview
2.4.2 Tuberculosis Diagnosis and Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 BD Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.5 Bio-Synth
2.5.1 Business Overview
2.5.2 Tuberculosis Diagnosis and Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bio-Synth Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.6 bioMérieux
2.6.1 Business Overview
2.6.2 Tuberculosis Diagnosis and Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 bioMérieux Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.7 Cepheid
2.7.1 Business Overview
2.7.2 Tuberculosis Diagnosis and Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Cepheid Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.8 Eiken Chemical
2.8.1 Business Overview
2.8.2 Tuberculosis Diagnosis and Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Eiken Chemical Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.9 Epistem
2.9.1 Business Overview
2.9.2 Tuberculosis Diagnosis and Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Epistem Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.10 Roche
2.10.1 Business Overview
2.10.2 Tuberculosis Diagnosis and Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Roche Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.11 GSK
2.11.1 Business Overview
2.11.2 Tuberculosis Diagnosis and Treatment Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 GSK Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.12 Hain Lifesciences
2.12.1 Business Overview
2.12.2 Tuberculosis Diagnosis and Treatment Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Hain Lifesciences Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.13 Hologic
2.13.1 Business Overview
2.13.2 Tuberculosis Diagnosis and Treatment Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Hologic Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.14 Labatec
2.14.1 Business Overview
2.14.2 Tuberculosis Diagnosis and Treatment Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Labatec Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.15 Lupin
2.15.1 Business Overview
2.15.2 Tuberculosis Diagnosis and Treatment Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Lupin Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.16 Otsuka Novel Products
2.16.1 Business Overview
2.16.2 Tuberculosis Diagnosis and Treatment Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Otsuka Novel Products Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.17 QIAGEN
2.17.1 Business Overview
2.17.2 Tuberculosis Diagnosis and Treatment Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 QIAGEN Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.18 Sandoz
2.18.1 Business Overview
2.18.2 Tuberculosis Diagnosis and Treatment Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Sandoz Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.19 Sanofi
2.19.1 Business Overview
2.19.2 Tuberculosis Diagnosis and Treatment Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Sanofi Tuberculosis Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
3 Global Tuberculosis Diagnosis and Treatment Market Competition, by Players
3.1 Global Tuberculosis Diagnosis and Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Tuberculosis Diagnosis and Treatment Players Market Share
3.2.2 Top 10 Tuberculosis Diagnosis and Treatment Players Market Share
3.3 Market Competition Trend
4 Global Tuberculosis Diagnosis and Treatment Market Size by Regions
4.1 Global Tuberculosis Diagnosis and Treatment Revenue and Market Share by Regions
4.2 North America Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
5 North America Tuberculosis Diagnosis and Treatment Revenue by Countries
5.1 North America Tuberculosis Diagnosis and Treatment Revenue by Countries (2013-2018)
5.2 USA Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
6 Europe Tuberculosis Diagnosis and Treatment Revenue by Countries
6.1 Europe Tuberculosis Diagnosis and Treatment Revenue by Countries (2013-2018)
6.2 Germany Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
6.4 France Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Tuberculosis Diagnosis and Treatment Revenue by Countries
7.1 Asia-Pacific Tuberculosis Diagnosis and Treatment Revenue by Countries (2013-2018)
7.2 China Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
7.5 India Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
8 South America Tuberculosis Diagnosis and Treatment Revenue by Countries
8.1 South America Tuberculosis Diagnosis and Treatment Revenue by Countries (2013-2018)
8.2 Brazil Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Tuberculosis Diagnosis and Treatment by Countries
9.1 Middle East and Africa Tuberculosis Diagnosis and Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Tuberculosis Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
10 Global Tuberculosis Diagnosis and Treatment Market Segment by Type
10.1 Global Tuberculosis Diagnosis and Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Tuberculosis Diagnosis and Treatment Market Forecast by Type (2018-2023)
10.3 Laboratory testing Revenue Growth Rate (2013-2023)
10.4 Nucleic acid tests Revenue Growth Rate (2013-2023)
10.5 Mantoux test Revenue Growth Rate (2013-2023)
10.6 Radiography Revenue Growth Rate (2013-2023)
10.7 Drug susceptibility test Revenue Growth Rate (2013-2023)
11 Global Tuberculosis Diagnosis and Treatment Market Segment by Application
11.1 Global Tuberculosis Diagnosis and Treatment Revenue Market Share by Application (2013-2018)
11.2 Tuberculosis Diagnosis and Treatment Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Government organizations Revenue Growth (2013-2018)
11.5 Individual Revenue Growth (2013-2018)
12 Global Tuberculosis Diagnosis and Treatment Market Size Forecast (2018-2023)
12.1 Global Tuberculosis Diagnosis and Treatment Market Size Forecast (2018-2023)
12.2 Global Tuberculosis Diagnosis and Treatment Market Forecast by Regions (2018-2023)
12.3 North America Tuberculosis Diagnosis and Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Tuberculosis Diagnosis and Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Tuberculosis Diagnosis and Treatment Revenue Market Forecast (2018-2023)
12.6 South America Tuberculosis Diagnosis and Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Tuberculosis Diagnosis and Treatment Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Tuberculosis Diagnosis and Treatment Picture
Table Product Specifications of Tuberculosis Diagnosis and Treatment
Table Global Tuberculosis Diagnosis and Treatment a
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
